You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
盤中異動 | 泰格醫藥盤中下跌7%,報於84.7港元

2022年1月5日14時19分,泰格醫藥(HK03347)盤中下跌7%,報於84.7港元,成交額達1.13億港元,換手率達到1.0%。

1月4日訊,泰格醫藥(03347)發佈公告,王如偉辭任公司副總經理。

12月31日,浙商證券:維持方達控股(01521)“買入”評級,收購美臨牀前公司,一體化CXO再加速。12月16日,瑞銀:維持泰格醫藥(03347)“買入”評級,目標價降29.6%至173.82港元。

最新的財務數據顯示,公司於2021年3季度,營業收入13.39億人民幣,淨利潤5.96億人民幣;營業收入同比增加58.56%,毛利潤同比增加48.03%,淨利潤同比增加62.5%。

盈立趨勢長盈模型最近一次交易信號,2021年12月17日出現觀望信號,觸發價格爲112.6港元(信號僅供參考)。

uSMART智能寫手的信息、數據均來自媒體公開報道,智能寫手不能保證其完全準確,內容僅供參考,不構成投資建議。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account